Voltage-gated sodium channels in cancer and their specific inhibitors

Yuan Bian1, Jiale Tuo1, Liangpeng He1

  • 1School of Life Science and Bio-Pharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, PR China.

PubMed

Insights

Voltage-gated sodium channels (VGSCs) are abnormally expressed in tumors, aiding cancer cell identification and metastasis. Blocking these channels offers a novel cancer treatment strategy.

Area of Science:

  • Molecular biology
  • Oncology
  • Neuroscience

Background:

  • Voltage-gated sodium channels (VGSCs) are crucial for action potential propagation in excitable cells.
  • Abnormal VGSC expression is a hallmark of various tumors, contrasting with low/absent expression in normal tissues.
  • Overexpression of VGSCs correlates with increased cancer cell invasion, metastasis, and overall metastatic behavior.

Purpose of the Study:

  • To review the structure and function of VGSCs.
  • To elucidate the correlation between VGSCs and cancer development and progression.
  • To provide an overview of current research on VGSC inhibitors for cancer therapy.

Main Methods:

  • Literature review of VGSC structure, function, and cancer association.
  • Analysis of studies on VGSC expression in different tumor types.
  • Compilation of data on subtype-selective VGSC inhibitors and clinical trials.

Main Results:

  • VGSCs play a significant role in tumor cell viability and identification.
  • VGSC overexpression enhances cancer cell metastasis and invasion.
  • Targeting VGSCs presents a promising therapeutic strategy for various cancers.

Conclusions:

  • VGSCs are critical players in cancer biology, influencing cell viability and metastasis.
  • Subtype-selective VGSC inhibitors are under active investigation for cancer treatment.
  • Further research into VGSC inhibitors holds potential for novel cancer therapies.

Related Concept Videos

Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
6.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.4K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
170